Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication

Código QR

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication

SARS-CoV-2 (the causative agent of COVID-19) is a major public health threat and one of two related coronaviruses that have caused epidemics in modern history. A method of screening potential infectible hosts for preemergent and future emergent coronaviruses would aid in mounting rapid response and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lily E. Adams, Kenneth H. Dinnon, Yixuan J. Hou, Timothy P. Sheahan, Mark T. Heise, Ralph S. Baric
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2021
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/f2e5f3b16cfd4ca9836689a6cafef5cf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Yanqiu Gong, et al.
Publicado: (2021)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zengyuan Zhang, et al.
Publicado: (2021)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Christopher J. Day, et al.
Publicado: (2021)

No species-level losses of s2m suggests critical role in replication of SARS-related coronaviruses
por: Clément Gilbert, et al.
Publicado: (2021)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
por: Yannick Galipeau, et al.
Publicado: (2021)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Jinsung Yang, et al.
Publicado: (2020)

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
por: Kushal Suryamohan, et al.
Publicado: (2021)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Jiwan Ge, et al.
Publicado: (2021)

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Wayne Vuong, et al.
Publicado: (2020)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
por: Van A Ngo, et al.
Publicado: (2021)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Jorge H. Rodriguez
Publicado: (2021)

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
por: Yusuke Higuchi, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Changhai Lei, et al.
Publicado: (2020)

SARS-CoV-2 variants reveal features critical for replication in primary human cells.
por: Marie O Pohl, et al.
Publicado: (2021)

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
por: Jackelyn Murray, et al.
Publicado: (2021)

Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
por: Van A Ngo, et al.
Publicado: (2021)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
por: Marta Targosz-Korecka, et al.
Publicado: (2021)

Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Jinsung Yang, et al.
Publicado: (2021)

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
por: Philippe Karoyan, et al.
Publicado: (2021)

Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction
por: Van A. Ngo, et al.
Publicado: (2021)

Investigating binding potential of carotenoid pathway bioactive molecules for ACE2 receptor of SARS-CoV-2: Possibility of a saffron based remedy for novel coronavirus!
por: Shabir Ahmad Ahmed, et al.
Publicado: (2021)

Rapid electrochemical detection of coronavirus SARS-CoV-2
por: Thanyarat Chaibun, et al.
Publicado: (2021)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Shiho Tanaka, et al.
Publicado: (2021)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
por: Georgina I. López-Cortés, et al.
Publicado: (2021)

Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective
por: Yulong Wei, et al.
Publicado: (2021)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
por: Narcis Fernandez-Fuentes, et al.
Publicado: (2021)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
por: Yanyun Du, et al.
Publicado: (2021)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko J, et al.
Publicado: (2020)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
por: Lihua Qu, et al.
Publicado: (2021)

In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment
por: Giovanni Sartore, et al.
Publicado: (2021)

Dinamika Interaksi Reseptor ACE2 dan SARS-CoV-2 Terhadap Manifestasi Klinis COVID-19
por: Risma Ikawaty
Publicado: (2020)

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
por: He C, et al.
Publicado: (2021)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Carolin Loos, et al.
Publicado: (2020)

Identification of Cellular Factors Required for SARS-CoV-2 Replication
por: Aleksandra Synowiec, et al.
Publicado: (2021)

The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Madeline Loffredo, et al.
Publicado: (2021)

SARS-CoV-2 infection and replication in human gastric organoids
por: Giovanni Giuseppe Giobbe, et al.
Publicado: (2021)

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
por: Monir Ejemel, et al.
Publicado: (2020)

PFOA induces alteration in DNA methylation regulators and SARS-CoV-2 targets Ace2 and Tmprss2 in mouse lung tissues
por: Saeed Ahmad, et al.
Publicado: (2021)